Serum vitamin D level and its relation with carotid intima-media thickness in type 2 diabetic patients: a cross-sectional observational study

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 2, 2016, Pages S55-S59

  Bhadra, R ^a   Choudhuri, A R ^a   Hazra, A ^a   Mukhopadhyay, J D ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; VITAMIN D; BIOLOGICAL MARKER;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; CARDIOMETABOLIC RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; IMMUNOTURBIDIMETRY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; CHEMISTRY; COMPLICATION; INDIA; METABOLISM; MIDDLE AGED; RISK FACTOR; SERUM;

ADULT; AGED; BIOMARKERS; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; RISK FACTORS; SERUM; VITAMIN D;

EID: 85027942513     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.01.025     Document Type: Article

References (39)

1. Harinarayan, C.V., Joshi, S.R., Vitamin D status in India - Its implications and remedial measures. J Assoc Physicians India 57 (2009), 40–48.
2. Knekt, P., Laaksonen, M., Mattila, C., Harkanen, T., Marniemi, J., Heliovaara, M., et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19 (2008), 666–671.
3. Ford, E.S., Ajanai, U.A., McGuire, L.C., Liu, S., Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28 (2005), 1228–1230.
4. Anderson, J.L., May, H.T., Horne, B.D., Bair, T.L., Hall, N.L., Carlquist, J.F., et al., for Intermountain Heart Collaborative (IHC) Study Group., Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106 (2010), 963–968.
5. Holick, M.F., Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 (2004), 362–371.
6. Bolland, M.J., Bacon, C.J., Horne, A.M., Mason, B.H., Ames, R.W., Wang, T.K., et al. Vitamin D insufficiency and health outcomes over 5 years in older women. Am J Clin Nutr 91 (2010), 82–89.
7. Forman, J.P., Giovannucci, E., Holmes, M.D., Bischoff-Ferrari, H.A., Tworoger, S.S., Willett, W.C., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 (2007), 1063–1069.
8. Melamed, M.L., Muntner, P., Michos, E.D., Uribarri, J., Weber, C., Sharma, J., et al. Serum 25- hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28 (2008), 1179–1185.
9. Giovannucci, E., Liu, Y., Hollis, B.W., Rimm, E.B., 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168 (2008), 1174–1180.
10. Zittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R., Stehle, P., Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol 41 (2003), 105–112.
11. Semba, R.D., Houston, D.K., Bandinelli, S., Sun, K., Cherubini, A., Cappola, A.R., et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 64 (2010), 203–209.
12. Zhao, G., Ford, E.S., Li, C., Croft, J.B., Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 30 (2012), 284–289.
13. Braam, L.A., Hoeks, A.P., Brouns, F., Hamulyak, K., Gerchhausen, M.J., Vermeer, C., Beneficial effects of vitamin D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thrombosis Haemostasis 91 (2004), 373–380.
14. Levin, A., Li, Y.C., Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?. Kidney Int 68 (2005), 1973–1981.
15. Grandi, N.C., Breitling, L.P., Brenner, H., Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51 (2010), 228–233.
16. Pittas, A.G., Chung, M., Trikalinos, T., Mitri, J., Brendel, M., Patel, K., et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152 (2010), 307–314.
17. Zitman-Gal, T., Green, J., Pasmanik-Chor, M., Oron-Karni, V., Bernheim, J., Benchetrit, S., Vitamin D and vascular smooth muscle cells: gene modulation following exposure to a diabetic-like environment. J Diabetes Metab 3 (2012), 1–9.
18. Li, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q., C ao P, 1,25-dihydroxy-vitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002), 229–238.
19. O'Leary, D.H., Polak, J.F., Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90 (2002), 18–21.
20. Teno, S., Uto, Y., Nagashima, H., Endoh, Y., Iwamoto, Y., Omori, Y., et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 23 (2000), 1401–1406.
21. Yamamoto, M., Egusa, G., Yamakido, M., Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM. Diabetes Care 20 (1997), 829–831.
22. Hayaishi-Okano, R., Yamasaki, Y., Katakami, N., Ohtoshi, K., Gorogawa, S., Kuroda, A., et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 25 (2002), 1432–1438.
23. Agewall, S., Wikstrand, J., Ljungman, S., Fagerberg, B., Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus. J Hypertension 13 (1995), 463–469.
24. Leinonen, E.S., Hiukka, A., Hurt-Camejo, E., Wiklund, O., Sarna, S.S., Mattson Hultén, L., et al. Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes. J Intern Med 256 (2004), 119–127.
25. Chen, Y., Kong, J., Sun, T., Li, G., Szeto, F.L., Liu, W., et al. 1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation. Arch Biochem Biophys 507 (2011), 241–247.
26. Bonora, E., Tessari, R., Micciolo, R., Zenere, M., Targher, G., Padovani, R., et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care 20 (1997), 627–631.
27. Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006), 247–254.
28. National Cholesterol Education Program, Executive summary of the third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 285 (2001), 2486–2497.
29. Reis, J.P., von Mühlen, D., Michos, E.D., Miller, E.R. 3rd., Appel, L.J., Araneta, M.R., et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 207 (2009), 585–590.
30. Timms, P.M., Mannan, N., Hitman, G.A., Noonan, K., Mills, P.G., Syndercombe-Court, D., et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?. Quarterly J Med 95 (2002), 787–796.
31. Sun, J., Kong, J., Duan, Y., Szeto, F.L., Liao, A., Madara, J.L., et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291 (2006), E315–E322.
32. Andress, D.L., Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 69 (2006), 33–43.
33. Hao, Y., Ma, X., Luo, Y., Xu, Y., Xiong, Q., Zhu, J., et al. Inverse association of serum vitamin D in relation to carotid intima-media thickness in Chinese postmenopausal women. PLoS One, 10, 2015, e0122803, 10.1371/journal.pone.0122803.
34. Satilmis, S., Celik, O., Biyik, I., Ozturk, D., Celik, K., Akın, F., et al. Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population. Bosn J Basic Med Sci 15 (2015), 67–72.
35. Juonala, M., Voipio, A., Pahkala, K., Viikari, J.S., Mikkilä, V., Kähönen, M., et al. Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. J Clin Endocrinol Metab 100 (2015), 1469–1476.
36. Strawbridge, R.J.A., Serum 25-hydroxy-vitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia 57 (2014), 1159–1172.
37. Serra-Planas, E., Aguilera, E., Granada, M.L., Soldevila, B., Salinas, I., Reverter, J.L., et al. High prevalence of vitamin D deficiency and lack of association with subclinical atherosclerosis in asymptomatic patients with Type 1 diabetes mellitus from a Mediterranean area. Acta Diabetol 52 (2015), 773–779.
38. Güvener, N., Tütüncü, N.B., Oto, A., Erbås, T., Major determinants of the carotid intima-media thickness in type 2 diabetic patients: age and body mass index. Endocr J 47 (2000), 525–533.
39. Elamin, M.B., Abu Elnour, N.O., Elamin, K.B., Fatourechi, M.M., Alkatib, A.A., Almandoz, J.P., et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96 (2011), 1931–1942.